Monthly Archives: January 2015

//January
30 01, 2015

Workplace Drug Testing Increasing in the UK

By |January 30th, 2015|Drug Testing|Comments Off on Workplace Drug Testing Increasing in the UK

Advanced technologies are making it possible to test drugs or blood samples rapidly. According to a recent report, four leading screening companies - Alere, Synergy Health, LGC Group and BioClinics - said that workplace drug testing has increased significantly in the UK. Two companies saw rises of 100% and 470% in number of tests carried [...]

29 01, 2015

FDA Approves New Vaccine for HPV

By |January 29th, 2015|HPV Vaccine|Comments Off on FDA Approves New Vaccine for HPV

The most common cause of cervical cancer is human papilloma virus (HPV). The United States Congress has designated January as Cervical Health Awareness Month and Cervical Cancer Screening Month. If detected at an early stage, the disease can be treated relatively easily. According to the Centers for Disease Control and Prevention (CDC), eight million women [...]

28 01, 2015

Avoiding Pre-analytical Errors in the Laboratory

By |January 28th, 2015|Laboratory Tests, Medical Laboratory Testing|Comments Off on Avoiding Pre-analytical Errors in the Laboratory

Official reports indicate that clinical laboratory results determine up to 60-70% of physician decisions about hospitalization, discharge, and prescription. Errors can occur in all stages of the testing process - the preanalytical, analytical and postanalytical phases. However, studies show that errors in pre-analytical stage predominate and are as high as 70%. Preanalytical errors can occur [...]

23 01, 2015

Roche Partnering with Meiji and Fedora to Battle Drug-resistant Bacterial Infections

By |January 23rd, 2015|Roche|Comments Off on Roche Partnering with Meiji and Fedora to Battle Drug-resistant Bacterial Infections

Roche, the world's largest biotech company and frontrunner in providing medicines in oncology, immunology, and infectious diseases has joined forces with Meiji Seika Pharma Co., Ltd. and Fedora Pharmaceuticals to fight increasing bacterial resistance to antibiotics. Under the agreement, Roche has obtained worldwide rights (except Japan) from both companies for development and commercialization of OP0595, [...]

22 01, 2015

Laboratory Testing for the Sunshine Vitamin

By |January 22nd, 2015|Laboratory Tests, Vitamin D Testing|Comments Off on Laboratory Testing for the Sunshine Vitamin

Recent reports predicted that the world Vitamin D testing market would grow at a CAGR of 32.36 percent over the period 2013-2018. According to the Research and Markets report, a key factors contributing to this market growth is the increase in aging and chronically ill populations worldwide. In the past, a test for vitamin D, [...]

21 01, 2015

New Drug for Malignant Melanoma Shows Promise in Laboratory Tests

By |January 21st, 2015|Laboratory Tests, Skin Cancer|Comments Off on New Drug for Malignant Melanoma Shows Promise in Laboratory Tests

The most deadly form of skin cancer, malignant melanoma occurs when some cells in the skin begin to develop abnormally. If not treated early, the condition can spread rapidly to the lymph nodes and other organs. Tests performed to investigate the outlook of the condition include sentinel lymph node biopsy, completion lymph node dissection or [...]

20 01, 2015

Beckman Coulter’s Access 25(OH) Vitamin D Total Assay Receives FDA Clearance

By |January 20th, 2015|Beckman Coulter|Comments Off on Beckman Coulter’s Access 25(OH) Vitamin D Total Assay Receives FDA Clearance

The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Beckman Coulter's Access 25(OH) Vitamin D Total assay. An important addition to the company's bone metabolism assay menu, this new assay is meant for use on the Access 2 and UniCel DxI immunoassay systems. It provides diagnostic confidence for vitamin D measurement, which [...]

19 01, 2015

Roche’s Blood Screening Assay Gets FDA Approval

By |January 19th, 2015|Roche|Comments Off on Roche’s Blood Screening Assay Gets FDA Approval

Roche, the leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics, has announced that the U.S. Food and Drug Administration (FDA) has approved its cobas® TaqScreen MPX Test, v2.0. This is the first nucleic acid test (NAT) to simultaneously detect and identify HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV) including [...]

16 01, 2015

Laboratory Professionals – The Unsung Heroes Behind the Scene

By |January 16th, 2015|Lab Equipment|Comments Off on Laboratory Professionals – The Unsung Heroes Behind the Scene

Medical laboratory scientists (MLS) or clinical laboratory scientists play an important role in saving lives every day by assisting with patient diagnosis and treatment. In the current complex healthcare system, these technicians ensure that the correct test is performed on the right person, at the right time. Physicians and other healthcare professionals make appropriate evidence-based [...]

15 01, 2015

Roche Launches New Viral Load Testing Assays for its Automated Molecular Diagnostic Systems

By |January 15th, 2015|Roche Diagnostics|Comments Off on Roche Launches New Viral Load Testing Assays for its Automated Molecular Diagnostic Systems

Roche has introduced new viral load monitoring assays, cobas HIV-1 and cobas HCV assays, for use on its fully automated molecular diagnostic systems, cobas 6800/8800. With these next generation viral load monitoring assays, clinicians can manage the treatment of patients infected with human immunodeficiency virus (HIV-1) or hepatitis C (HCV). The viral load portfolio on [...]